Search

Your search keyword '"Patel, Vipul M."' showing total 4 results
Start Over Author "Patel, Vipul M." Journal journal of clinical oncology
4 results on '"Patel, Vipul M."'

1. Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and PD(L)-1inhibitors (IO): Primary results from the phase 3 EVOKE-01 study.

Author

Paz-Ares, Luis G., primary, Juan-Vidal, Oscar, additional, Mountzios, Giannis Socrates, additional, Felip, Enriqueta, additional, Reinmuth, Niels, additional, de Marinis, Filippo, additional, Girard, Nicolas, additional, Patel, Vipul M., additional, Takahama, Takayuki, additional, Owen, Scott Peter, additional, Reznick, Douglas, additional, Badin, Firas Benyamine, additional, Cicin, Irfan, additional, Mekan, Sabeen Fatima, additional, Patel, Riddhi, additional, Zhang, Eric, additional, Karumanchi, Divyadeep, additional, and Garassino, Marina Chiara, additional

Published
2024
Full Text
View/download PDF

2. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.

Author

Paz-Ares, Luis G., Juan-Vidal, Oscar, Mountzios, Giannis S., Felip, Enriqueta, Reinmuth, Niels, de Marinis, Filippo, Girard, Nicolas, Patel, Vipul M., Takahama, Takayuki, Owen, Scott P., Reznick, Douglas M., Badin, Firas B., Cicin, Irfan, Mekan, Sabeen, Patel, Riddhi, Zhang, Eric, Karumanchi, Divyadeep, and Garassino, Marina Chiara

Published
2024
Full Text
View/download PDF

3. The safety and efficacy of PEN-221 somatostatin analog (SSA)-DM1 conjugate in patients (PTS) with advanced GI mid-gut neuroendocrine tumor (NET): Phase 2 results.

Author

Halperin, Daniel M., primary, Johnson, Melissa Lynne, additional, Chan, Jennifer A., additional, Hart, Lowell L., additional, Cook, Natalie, additional, Patel, Vipul M., additional, Schlechter, Benjamin L., additional, Cave, Judith, additional, Dowlati, Afshin, additional, Blaszkowsky, Lawrence Scott, additional, Meyer, Tim, additional, Eads, Jennifer Rachel, additional, Culp, Daniel, additional, Kriksciukaite, Kristina, additional, Mei, Laura, additional, Bilodeau, Mark, additional, Bloss, Jeffrey, additional, and Kulke, Matthew H., additional

Published
2021
Full Text
View/download PDF

4. Serum and tumor biomarkers to predict outcome in the eLung trial, a multicenter, randomized phase IIb study of standard platinum doublets (PD) plus cetuximab (CET) as first-line treatment of advanced non-small cell lung cancer (NSCLC).

Author

Miller, Paul J. E., primary, Walker, Mark S., additional, Tauer, Kurt W., additional, Atkins, James, additional, Sivarajan, Kulumani M, additional, Patel, Vipul M., additional, Bastos, Bruno R., additional, Meyer, Krista, additional, Roder, Joanna, additional, Uyeda, Lisa, additional, Salazar, Suzanne, additional, Langer, Corey J., additional, Socinski, Mark A., additional, Spigel, David R., additional, and Schwartzberg, Lee Steven, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results